Works matching IS 11707690 AND DT 2016 AND VI 34 AND IP 11
Results: 11
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Methodological Review of US Budget-Impact Models for New Drugs.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article
From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Discretely Integrated Condition Event Simulation for Pharmacoeconomics.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Response to Letter to the Editor Regarding Discretely Integrated Condition Event Simulation for Pharmacoeconomics.
- Published in:
- 2016
- By:
- Publication type:
- Letter
The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence.
- Published in:
- 2016
- By:
- Publication type:
- journal article